Overcoming barriers and thresholds - Signaling of oligomeric Aβ through the prion protein to Fyn

Molecular Neurodegeneration

Volumn 8, Issue 1, 2013, Pages

  Wang, Hansen ^a   Ren, Carl He ^a,b   Gunawardana, C Geeth ^a   Schmitt Ulms, Gerold ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer disease; Amyloid peptide; Excitotoxicity; Fyn; Prion protein; Tau

Indexed keywords

AMYLOID BETA PROTEIN; CAVEOLIN 1; FIBRONECTIN; GLYCOSYLPHOSPHATIDYLINOSITOL; INTEGRIN; LAMININ RECEPTOR; MEMBRANE PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE CELL ADHESION MOLECULE; OLIGOMERIC AMYLOID BETA PEPTIDE; PRION PROTEIN; PROTEIN KINASE FYN; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CELL MEMBRANE; CROSS LINKING; EXCITOTOXICITY; EXPERIMENTAL DESIGN; EXTRACELLULAR MATRIX; HUMAN; INTRACELLULAR SIGNALING; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; HUMANS; PROTO-ONCOGENE PROTEINS C-FYN; PRPC PROTEINS; SIGNAL TRANSDUCTION;

EID: 84880087894     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-8-24     Document Type: Review

References (91)

1. Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Ittner LM, Gotz J, Nat Rev Neurosci 2011 12 65 72 21309096
2. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, et al. Proc Natl Acad Sci 1998 95 6448 6453 10.1073/pnas.95.11.6448 9600986
3. Tau interacts with src-family non-receptor tyrosine kinases. Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G, J Cell Sci 1998 111 Pt 21 3167 3177 9763511
4. Tau is essential to beta -amyloid-induced neurotoxicity. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A, Proc Natl Acad Sci 2002 99 6364 6369 10.1073/pnas.092136199 11959919
5. Amyloid-beta/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, Wu T, Hamto P, Devidze N, Yu GQ, et al. J Neurosci 2011 31 700 711 10.1523/JNEUROSCI.4152-10.2011 21228179
6. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van ersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, et al. Cell 2010 142 387 397 10.1016/j.cell.2010.06.036 20655099
7. Fyn-tau-amyloid: a toxic triad. Haass C, Mandelkow E, Cell 2010 142 356 358 10.1016/j.cell.2010.07.032 20691893
8. Neuronal receptors as targets for the action of amyloid-beta protein (Abeta) in the brain. Patel AN, Jhamandas JH, Expert Rev Mol Med 2012 14 2 22261393
9. Postsynaptic receptors for amyloid-beta oligomers as mediators of neuronal damage in Alzheimer's disease. Dinamarca MC, Rios JA, Inestrosa NC, Front Physiol 2012 3 464 23267328
10. Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM, Nat Neurosci 2012 15 1227 1235 10.1038/nn.3178 22820466
11. Alzheimer's disease brain-derived amyloid-beta-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. Barry AE, Klyubin I, Mc Donald JM, Mably AJ, Farrell MA, Scott M, Walsh DM, Rowan MJ, J Neurosci 2011 31 7259 7263 10.1523/JNEUROSCI.6500-10.2011 21593310
12. Prion protein and Abeta-related synaptic toxicity impairment. Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J, Mansuy IM, Aguzzi A, EMBO Mol Med 2010 2 306 314 10.1002/emmm.201000082 20665634
13. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. Chen S, Yadav SP, Surewicz WK, J Biol Chem 2010 285 26377 26383 10.1074/jbc.M110.145516 20576610
14. Cellular prion protein is essential for oligomeric amyloid-beta-induced neuronal cell death. Kudo W, Lee HP, Zou WQ, Wang X, Perry G, Zhu X, Smith MA, Petersen RB, Lee HG, Hum Mol Genet 2011 21 1138 1144 22100763
15. Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain. Zou WQ, Xiao X, Yuan J, Puoti G, Fujioka H, Wang X, Richardson S, Zhou X, Zou R, Li S, et al. J Biol Chem 2011 286 15095 15105 10.1074/jbc.M110.199356 21393248
16. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E, Tapella L, Colombo L, Manzoni C, Borsello T, et al. Proc Natl Acad Sci 2010 107 2295 2300 10.1073/pnas.0911829107 20133875
17. Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. Cisse M, Sanchez PE, Kim DH, Ho K, Yu GQ, Mucke L, J Neurosci 2011 31 10427 10431 10.1523/JNEUROSCI.1459-11.2011 21775587
18. Prion protein in Alzheimer's pathogenesis: a hot and controversial issue. Benilova I, De Strooper B, EMBO Mol Med 2010 2 289 290 10.1002/emmm.201000088 20698011
19. Prion protein at the crossroads of physiology and disease. Biasini E, Turnbaugh JA, Unterberger U, Harris DA, Trends Neurosci 2012 35 92 103 10.1016/j.tins.2011.10.002 22137337
20. Prion protein is a key determinant of alcohol sensitivity through the modulation of N-methyl-D-aspartate receptor (NMDAR) activity. Petit-Paitel A, Menard B, Guyon A, Beringue V, Nahon JL, Zsurger N, Chabry J, PLoS One 2012 7 34691 10.1371/journal.pone.0034691 22536327
21. The many faces of tau. Morris M, Maeda S, Vossel K, Mucke L, Neuron 2011 70 410 426 10.1016/j.neuron.2011.04.009 21555069
22. Alzheimer's Disease: a prion protein connection. Cisse M, Mucke L, Nature 2009 457 1090 1091 10.1038/4571090a 19242462
23. The Prion's elusive reason for being. Aguzzi A, Baumann F, Bremer J, Annu Rev Neurosci 2008 31 439 477 10.1146/annurev.neuro.31.060407.125620 18558863
24. Is, indeed, the prion protein a Harlequin servant of "many" masters? Sorgato MC, Peggion C, Bertoli A, Prion 2009 3 202 205 10.4161/pri.3.4.10012 19887913
25. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. Santuccione A, Sytnyk V, Leshchyns'ka I, Schachner M, J Cell Biol 2005 169 341 354 10.1083/jcb.200409127 15851519
26. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE, Prusiner SB, J Mol Biol 2001 314 1209 1225 10.1006/jmbi.2000.5183 11743735
27. Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones. Watts JC, Huo H, Bai Y, Ehsani S, Jeon AH, Shi T, Daude N, Lau A, Young R, Xu L, et al. PLoS Pathog 2009 5 1000608 10.1371/journal.ppat.1000608 19798432
28. Signal transduction through prion protein. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O, Science 2000 289 1925 1928 10.1126/science.289.5486.1925 10988071
29. The Complex PrPc-Fyn couples human oligomeric abeta with pathological Tau changes in Alzheimer's disease. Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA, Aguzzi A, Lesne SE, J Neurosci 2012 32 16857 16871 10.1523/JNEUROSCI.1858-12.2012 23175838
30. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Maness PF, Schachner M, Nat Neurosci 2007 10 19 26 10.1038/nn1827 17189949
31. Cosignaling of NCAM via lipid rafts and the FGF receptor is required for neuritogenesis. Niethammer P, Delling M, Sytnyk V, Dityatev A, Fukami K, Schachner M, J Cell Biol 2002 157 521 532 10.1083/jcb.200109059 11980923
32. Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Schmitt-Ulms G, Hansen K, Liu J, Cowdrey C, Yang J, DeArmond SJ, Cohen FE, Prusiner SB, Baldwin MA, Nat Biotech 2004 22 724 731 10.1038/nbt969
33. NCAM-dependent neurite outgrowth is inhibited in neurons from Fyn-minus mice. Beggs HE, Soriano P, Maness PF, J Cell Biol 1994 127 825 833 10.1083/jcb.127.3.825 7962063
34. RPTPalpha is essential for NCAM-mediated p59fyn activation and neurite elongation. Bodrikov V, Leshchyns'ka I, Sytnyk V, Overvoorde J, den Hertog J, Schachner M, J Cell Biol 2005 168 127 139 15623578
35. Protein tyrosine phosphatase alpha (PTPalpha) and contactin form a novel neuronal receptor complex linked to the intracellular tyrosine kinase fyn. Zeng L, D'Alessandri L, Kalousek MB, Vaughan L, Pallen CJ, J Cell Biol 1999 147 707 714 10.1083/jcb.147.4.707 10562275
36. Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Su J, Muranjan M, Sap J, Current biology: CB 1999 9 505 511 10.1016/S0960-9822(99)80234-6 10339427
37. RPTP-alpha acts as a transducer of mechanical force on alphav/beta3-integrin-cytoskeleton linkages. von Wichert G, Jiang G, Kostic A, De Vos K, Sap J, Sheetz MP, J Cell Biol 2003 161 143 153 10.1083/jcb.200211061 12682088
38. The receptor-like protein-tyrosine phosphatase, RPTP alpha, is phosphorylated by protein kinase C on two serines close to the inner face of the plasma membrane. Tracy S, van der Geer P, Hunter T, J Biol Chem 1995 270 10587 10594 10.1074/jbc.270.18.10587 7537734
39. Mitotic activation of protein-tyrosine phosphatase alpha and regulation of its Src-mediated transforming activity by its sites of protein kinase C phosphorylation. Zheng XM, Resnick RJ, Shalloway D, J Biol Chem 2002 277 21922 21929 10.1074/jbc.M201394200 11923305
40. NCAM induces CaMKIIalpha-mediated RPTPalpha phosphorylation to enhance its catalytic activity and neurite outgrowth. Bodrikov V, Sytnyk V, Leshchyns'ka I, den Hertog J, Schachner M, J Cell Biol 2008 182 1185 1200 10.1083/jcb.200803045 18809727
41. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, Rieger R, Krasemann S, Deslys JP, Dormont D, Lasmezas CI, Weiss S, EMBO J 2001 20 5863 5875 10.1093/emboj/20.21.5863 11689427
42. Integrin structure, activation, and interactions. Campbell ID, Humphries MJ, Cold Spring Harb Perspect Biol 2011 3 1 14
43. Peptide G, containing the binding site of the 67-kDa laminin receptor, increases and stabilizes laminin binding to cancer cells. Magnifico A, Tagliabue E, Buto S, Ardini E, Castronovo V, Colnaghi MI, Menard S, J Biol Chem 1996 271 31179 31184 10.1074/jbc.271.49.31179 8940117
44. Laminin receptor expression and function in small-cell lung carcinoma. Pellegrini R, Martignone S, Menard S, Colnaghi MI, Int J Cancer Suppl 1994 8 116 120 8194888
45. Co-regulation and physical association of the 67-kDa monomeric laminin receptor and the alpha6beta4 integrin. Ardini E, Tagliabue E, Magnifico A, Buto S, Castronovo V, Colnaghi MI, Menard S, J Biol Chem 1997 272 2342 2345 10.1074/jbc.272.4.2342 8999943
46. The L1 adhesion molecule is a cellular ligand for VLA-5. Ruppert M, Aigner S, Hubbe M, Yagita H, Altevogt P, J Cell Biol 1995 131 1881 1891 10.1083/jcb.131.6.1881 8557754
47. A single immunoglobulin-like domain of the human neural cell adhesion molecule L1 supports adhesion by multiple vascular and platelet integrins. Felding-Habermann B, Silletti S, Mei F, Siu CH, Yip PM, Brooks PC, Cheresh DA, O'Toole TE, Ginsberg MH, Montgomery AM, J Cell Biol 1997 139 1567 1581 10.1083/jcb.139.6.1567 9396761
48. PTP alpha regulates integrin-stimulated FAK autophosphorylation and cytoskeletal rearrangement in cell spreading and migration. Zeng L, Si X, Yu WP, Le HT, Ng KP, Teng RM, Ryan K, Wang DZ, Ponniah S, Pallen CJ, J Cell Biol 2003 160 137 146 10.1083/jcb.200206049 12515828
49. Integrin-induced tyrosine phosphorylation of protein-tyrosine phosphatase-alpha is required for cytoskeletal reorganization and cell migration. Chen M, Chen SC, Pallen CJ, J Biol Chem 2006 281 11972 11980 10.1074/jbc.M600561200 16507567
50. The caveolin proteins. Williams TM, Lisanti MP, Genome Biol 2004 5 214 10.1186/gb-2004-5-3-214 15003112
51. Src tyrosine kinases, galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. Li S, Couet J, Lisanti MP, J Biol Chem 1996 271 29182 29190 10.1074/jbc.271.46.29182 8910575
52. Cellular prion protein and caveolin-1 interaction in a neuronal cell line precedes Fyn/Erk 1/2 signal transduction. Toni M, Spisni E, Griffoni C, Santi S, Riccio M, Lenaz P, Tomasi V, J Biomed Biotechnol 2006 2006 69469 17489019
53. PrPc activation induces neurite outgrowth and differentiation in PC12 cells: role for caveolin-1 in the signal transduction pathway. Pantera B, Bini C, Cirri P, Paoli P, Camici G, Manao G, Caselli A, J Neurochem 2009 110 194 207 10.1111/j.1471-4159.2009.06123.x 19457127
54. One-Step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R, Cell 2013 153 910 918 10.1016/j.cell.2013.04. 025 23643243
55. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Zhang B, Cell 2013 153 707 720 10.1016/j.cell.2013.03.030 23622250
56. Beyond 'furballs' and 'dumpling soups'-towards a molecular architecture of signaling complexes and networks. Lewitzky M, Simister PC, Feller SM, FEBS Lett 2012 586 2740 2750 10.1016/j.febslet.2012.04.029 22710161
57. The comprehensive native interactome of a fully functional tagged prion protein. Rutishauser D, Mertz KD, Moos R, Brunner E, Rulicke T, Calella AM, Aguzzi A, PLoS One 2009 4 4446 10.1371/journal.pone.0004446 19209230
58. The in vivo brain interactome of the amyloid precursor protein. Bai Y, Markham K, Chen F, Weerasekera R, Watts J, Horne P, Wakutani Y, Bagshaw R, Mathews PM, Fraser PE, et al. Mol Cell Proteomics 2008 7 15 34 17934213
59. Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Borchelt DR, Rogers M, Stahl N, Telling G, Prusiner SB, Glycobiology 1993 3 319 329 10.1093/glycob/3.4.319 7691278
60. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. Naslavsky N, Stein R, Yanai A, Friedlander G, Taraboulos A, J Biol Chem 1997 272 6324 6331 10.1074/jbc.272.10. 6324 9045652
61. Prion protein-mediated toxicity of amyloid-beta oligomers requires lipid rafts and the transmembrane LRP1. Rushworth JV, Griffiths HH, Watt NT, Hooper NM, J Biol Chem 2013 288 8935 8951 10.1074/jbc.M112.400358 23386614
62. Mysteries of the cell. Do lipid rafts exist? Leslie M, Science 2011 334 1046 1047 22116853
63. Lipid rafts as a membrane-organizing principle. Lingwood D, Simons K, Science 2010 327 46 50 10.1126/science.1174621 20044567
64. A lipid raft-associated 67kDa laminin receptor mediates suppressive effect of epigallocatechin-3-O-gallate on FcepsilonRI expression. Fujimura Y, Yamada K, Tachibana H, Biochem Biophys Res Commun 2005 336 674 681 10.1016/j.bbrc.2005.08.146 16140266
65. Hotspots of GPI-anchored proteins and integrin nanoclusters function as nucleation sites for cell adhesion. van Zanten TS, Cambi A, Koopman M, Joosten B, Figdor CG, Garcia-Parajo MF, Proc Natl Acad Sci USA 2009 106 18557 18562 10.1073/pnas.0905217106 19850864
66. Beta1 integrin-mediated activation of focal adhesion kinase and its association with Fyn and Zap-70 in human NK cells. Rabinowich H, Manciulea M, Herberman RB, Whiteside TL, J Immunol 1996 157 3860 3868 8892616
67. Transmembrane form agrin-induced process formation requires lipid rafts and the activation of Fyn and MAPK. Ramseger R, White R, Kroger S, J Biol Chem 2009 284 7697 7705 10.1074/jbc.M806719200 19139104
68. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM, Nature 2009 457 1128 1132 10.1038/nature07761 19242475
69. Alpha2beta1 and alphaVbeta1 integrin signaling pathways mediate amyloid-beta-induced neurotoxicity. Wright S, Malinin NL, Powell KA, Yednock T, Rydel RE, Griswold-Prenner I, Neurobiol Aging 2007 28 226 237 10.1016/j.neurobiolaging.2005.12.002 16448724
70. Abeta inhibition of ionic conductance in mouse basal forebrain neurons is dependent upon the cellular prion protein PrPC. Alier K, Ma L, Yang J, Westaway D, Jhamandas JH, J Neurosci 2011 31 16292 16297 10.1523/JNEUROSCI.4367-11.2011 22072680
71. Human amylin actions on rat cholinergic basal forebrain neurons: antagonism of beta-amyloid effects. Jhamandas JH, Harris KH, Cho C, Fu W, MacTavish D, J Neurophysiol 2003 89 2923 2930 10.1152/jn.01138.2002 12611974
72. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. Kuwasako K, Shimekake Y, Masuda M, Nakahara K, Yoshida T, Kitaura M, Kitamura K, Eto T, Sakata T, J Biol Chem 2000 275 29602 29609 10.1074/jbc.M004534200 10882736
73. Amyloid beta (Abeta) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways. Fu W, Ruangkittisakul A, MacTavish D, Shi JY, Ballanyi K, Jhamandas JH, J Biol Chem 2012 287 18820 18830 10.1074/jbc.M111.331181 22500019
74. Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Hay DL, Christopoulos G, Christopoulos A, Poyner DR, Sexton PM, Mol Pharmacol 2005 67 1655 1665 10.1124/mol.104.008615 15692146
75. Regulation of NMDA receptors by the tyrosine kinase Fyn. Trepanier CH, Jackson MF, MacDonald JF, FEBS J 2012 279 12 19 10.1111/j.1742-4658.2011.08391.x 21985328
76. Src family kinases: modulators of neurotransmitter receptor function and behavior. Ohnishi H, Murata Y, Okazawa H, Matozaki T, Trends Neurosci 2011 34 629 637 10.1016/j.tins.2011.09.005 22051158
77. Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420. Nguyen TH, Liu J, Lombroso PJ, J Biol Chem 2002 277 24274 24279 10.1074/jbc.M111683200 11983687
78. Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T, Luo J, Thompson JA, Schraven BL, Philips MR, Neel BG, Mol Cell 2004 13 341 355 10.1016/S1097-2765(04)00050-4 14967142
79. Regulation of the Src tyrosine kinase and Syp tyrosine phosphatase by their cellular association. Peng ZY, Cartwright CA, Oncogene 1995 11 1955 1962 7478513
80. The regulation of N-methyl-D-aspartate receptors by Src kinase. Groveman BR, Feng S, Fang XQ, Pflueger M, Lin SX, Bienkiewicz EA, Yu X, FEBS J 2012 279 20 28 10.1111/j.1742-4658.2011.08413.x 22060915
81. Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J, J Neurosci 2002 22 698 707 11826099
82. A unique role for Fyn in CNS myelination. Sperber BR, Boyle-Walsh EA, Engleka MJ, Gadue P, Peterson AC, Stein PL, Scherer SS, McMorris FA, J Neurosci 2001 21 2039 2047 11245687
83. An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation. Laursen LS, Chan CW, ffrench-Constant C, J Neurosci 2009 29 9174 9185 10.1523/JNEUROSCI.5942-08.2009 19625508
84. Fyn mediates transforming growth factor-beta1-induced down-regulation of E-cadherin in human A549 lung cancer cells. Kim AN, Jeon WK, Lim KH, Lee HY, Kim WJ, Kim BC, Biochem Biophys Res Commun 2011 407 181 184 10.1016/j.bbrc.2011.02. 134 21371426
85. Reduced surface expression of epithelial E-cadherin evoked by interferon-gamma is Fyn kinase-dependent. Smyth D, Leung G, Fernando M, McKay DM, PLoS One 2012 7 38441 10.1371/journal.pone.0038441 22715382
86. Alphavbeta6-Fyn signaling promotes oral cancer progression. Li X, Yang Y, Hu Y, Dang D, Regezi J, Schmidt BL, Atakilit A, Chen B, Ellis D, Ramos DM, J Biol Chem 2003 278 41646 41653 10.1074/jbc.M306274200 12917446
87. Fyn: a novel molecular target in cancer. Saito YD, Jensen AR, Salgia R, Posadas EM, Cancer 2010 116 1629 1637 10.1002/cncr.24879 20151426
88. Axonal cell-adhesion molecule L1 in CNS myelination. Barbin G, Aigrot MS, Charles P, Foucher A, Grumet M, Schachner M, Zalc B, Lubetzki C, Neuron Glia Biol 2004 1 65 72 18634607
89. Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination. Kramer EM, Klein C, Koch T, Boytinck M, Trotter J, J Biol Chem 1999 274 29042 29049 10.1074/jbc.274.41.29042 10506155
90. Axonal prion protein is required for peripheral myelin maintenance. Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, Steele AD, Toyka KV, Nave KA, Weis J, Aguzzi A, Nat Neurosci 2010 13 310 318 10.1038/nn.2483 20098419
91. Regulation of embryonic cell adhesion by the prion protein. Malaga-Trillo E, Solis GP, Schrock Y, Geiss C, Luncz L, Thomanetz V, Stuermer CA, PLoS Biol 2009 7 55 10.1371/journal.pbio.1000055 19278297